These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 16388412)

  • 1. Thrombotic thrombocytopenic purpura: a diagnostic and therapeutic challenge.
    Kwaan HC
    Semin Thromb Hemost; 2005 Dec; 31(6):615-24. PubMed ID: 16388412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenicity of von Willebrand factor in thrombotic thrombocytopenic purpura: reconsideration of treatment with cryopoor plasma.
    Raife TJ; Friedman KD; Dwyre DM
    Transfusion; 2006 Jan; 46(1):74-9. PubMed ID: 16398733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing paradigm of thrombotic thrombocytopenic purpura.
    Raife TJ
    Semin Thromb Hemost; 2005 Dec; 31(6):641-51. PubMed ID: 16388415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical issues in ADAMTS13 testing and emerging therapies in thrombotic thrombocytopenic purpura.
    Cataland SR; Wu HM
    Semin Hematol; 2011 Oct; 48(4):242-50. PubMed ID: 22000089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
    Sadler JE
    Blood; 2008 Jul; 112(1):11-8. PubMed ID: 18574040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of thrombotic thrombocytopenic purpura: ADAMTS13 deficiency and beyond.
    Lian EC
    Semin Thromb Hemost; 2005 Dec; 31(6):625-32. PubMed ID: 16388413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: implications for selection of plasma preparations for thrombotic thrombocytopenic purpura treatment.
    Hori Y; Hayakawa M; Isonishi A; Soejima K; Matsumoto M; Fujimura Y
    Transfusion; 2013 Dec; 53(12):3192-202. PubMed ID: 23560518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of von Willebrand protease in aetiopathogenesis of thrombotic thrombocytopenic purpura].
    Suvajdzić-Vuković N
    Srp Arh Celok Lek; 2007; 135(5-6):360-6. PubMed ID: 17633329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and clinical application of a new method for detecting ADAMTS13 activity.
    Wang AY; Dong NZ; Ma ZN; Zhang JY; Su J; Ruan CG
    Chin Med J (Engl); 2010 Jul; 123(14):1859-63. PubMed ID: 20819568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Structure and function of ADAMTS13 protease and its relation with diagnosis and treatment of TTP].
    Wang Q; Han Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1157-61. PubMed ID: 25130848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The value of von Willebrand factor pro-peptide and ADAMTS13 in diagnosis of thrombotic thrombocytopenic purpura].
    Ji J; Liu T; Meng WT; Lu ZP
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 42(6):807-10. PubMed ID: 22332547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
    Zhou Z; Nguyen TC; Guchhait P; Dong JF
    Semin Thromb Hemost; 2010 Feb; 36(1):71-81. PubMed ID: 20391298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keeping von Willebrand Factor under Control: Alternatives for ADAMTS13.
    Tersteeg C; Fijnheer R; Pasterkamp G; de Groot PG; Vanhoorelbeke K; de Maat S; Maas C
    Semin Thromb Hemost; 2016 Feb; 42(1):9-17. PubMed ID: 26595154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic thrombocytopenic purpura-what is new?
    Shah N; Sarode R
    J Clin Apher; 2013 Feb; 28(1):30-5. PubMed ID: 23420593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.
    Tersteeg C; Verhenne S; Roose E; Schelpe AS; Deckmyn H; De Meyer SF; Vanhoorelbeke K
    Expert Rev Hematol; 2016; 9(2):209-21. PubMed ID: 26581428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ADAMTS13 in the pathogenesis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    George JN
    Clin Adv Hematol Oncol; 2005 Aug; 3(8):627-32. PubMed ID: 16167049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current insight into thrombotic thrombocytopenic purpura.
    Verbeke L; Delforge M; Dierickx D
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):3-10. PubMed ID: 19851089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic thrombocytopenic purpura: basic pathophysiology and therapeutic strategies.
    Crawley JT; Scully MA
    Hematology Am Soc Hematol Educ Program; 2013; 2013():292-9. PubMed ID: 24319194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].
    Schiphorst RH; van de Kar NC; van den Heuvel LP
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2422-4. PubMed ID: 14694551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.